MA14.05 A Randomized Phase III Trial of Fruquintinib Versus Placebo in Patients with Advanced Non-Small Cell Lung Cancer (FALUCA)
S. Lu,G. Chen,Y. Sun,S. Sun,J. Chang,Y. Yao,Z. Chen, F. Ye,J. Lu,J. Shi,J. He,X. Liu, Y. Zhang,Z. Liu, J. Fang,Y. Cheng,C. Hu,W. Mao,Y. Hu,Y. Gong, L. Shan, Z. Yang,Y. Song,W. Li, C. Bai,B. Wang,R. Ma,Z. Zheng,M. Liu,Z. Jie, L. Cao, W. Liao, H. Pan,D. Huang,Y. Chen,J. Yang, S. Qin, S. Ma,L. Liang,J. Zhou,M. Tao,Y. Huang,F. Qiu,Y. Hua, W. Su JOURNAL OF THORACIC ONCOLOGY（2019）
关键词
Fruquintinib,advanced NSCLC,Vascular Endothelial Growth Factor Receptor
AI 理解论文
溯源树
样例
